Cargando…
Exploring Synthetic Dihydrobenzofuran and Benzofuran Neolignans as Antiprotozoal Agents against Trypanosoma cruzi
Chagas disease is a neglected tropical disease that affects more than 8 million people. Although there are therapies against this disease, the search for new drugs is important because the current treatments show limited effectiveness and high toxicity. In this work, eighteen dihydrobenzofuran-type...
Autores principales: | Pagotti, Mariana C., Dias, Herbert J., Candido, Ana Carolina B. B., Oliveira, Thaís A. S., Borges, Alexandre, Oliveira, Nicoli D., Lopes, Carla D., Orenha, Renato P., Parreira, Renato L. T., Crotti, Antônio E. M., Magalhães, Lizandra G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052957/ https://www.ncbi.nlm.nih.gov/pubmed/36986617 http://dx.doi.org/10.3390/pharmaceutics15030754 |
Ejemplares similares
-
Synthesis and Structure–Activity Relationship
of Dehydrodieugenol B Neolignans against Trypanosoma cruzi
por: Sear, Claire E., et al.
Publicado: (2020) -
Fluorinated Benzofuran and Dihydrobenzofuran as Anti-Inflammatory and Potential Anticancer Agents
por: Ayoub, Abeer J., et al.
Publicado: (2023) -
Thio- and selenosemicarbazones as antiprotozoal agents against Trypanosoma cruzi and Trichomonas vaginalis
por: Ibáñez-Escribano, Alexandra, et al.
Publicado: (2022) -
Antiprotozoal Activity of Benzoylthiourea Derivatives against Trypanosoma cruzi: Insights into Mechanism of Action
por: Pereira, Patrícia Morais Lopes, et al.
Publicado: (2023) -
In vitro anti-Trypanosoma cruzi activity enhancement of curcumin by its monoketone tetramethoxy analog diveratralacetone
por: Souza, Julia M., et al.
Publicado: (2021)